Understanding how IRGM proteins affect immunity to gut bacteria
Role of IRGM proteins in immunity to enteric bacteria
This study is looking at how a specific gene called IRGM affects the immune system's ability to fight off certain bacteria in the gut, which could help us understand why some people get Crohn's disease and lead to better treatments for it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10669222 on NIH RePORTER |
What this research studies
This research investigates the role of the IRGM gene in regulating the immune response to enteric bacteria, particularly in relation to Crohn's disease. By studying how IRGM influences autophagy and the clearance of bacteria in the intestines, the research aims to uncover the mechanisms that lead to Crohn's disease susceptibility. The approach includes examining immune cell functions and their interactions with bacteria, using mouse models to simulate human conditions. This could lead to new insights into potential therapeutic targets for improving treatment and diagnosis of Crohn's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Crohn's disease or those with a family history of the condition.
Not a fit: Patients without any gastrointestinal disorders or those not affected by Crohn's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and diagnostics for patients with Crohn's disease.
How similar studies have performed: Previous research has shown that understanding genetic factors like IRGM can lead to significant advancements in treating autoimmune diseases, suggesting a promising avenue for this investigation.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Taylor, Gregory a — Duke University
- Study coordinator: Taylor, Gregory a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.